US 10610527
Methods for treating immunodeficiency disease
granted A61KA61K31/395A61K31/4709
Quick answer
US patent 10610527 (Methods for treating immunodeficiency disease) held by X4 Pharmaceuticals, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/395, A61K31/4709, A61K9/0053, A61K9/485